-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ADgEzcpPB7+kPcW5GnZUa6IE1cHC8KWPfjoBVyjFGoJTA4uvDxgrvbJC8v5GxqQt 74NwDyJej4LOcwif2t4thA== 0001238935-07-000015.txt : 20070629 0001238935-07-000015.hdr.sgml : 20070629 20070629200314 ACCESSION NUMBER: 0001238935-07-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070629 FILED AS OF DATE: 20070629 DATE AS OF CHANGE: 20070629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TWOMEY CHRISTOPHER J CENTRAL INDEX KEY: 0001238935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 07952675 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-06-29 1 0000834306 BIOSITE INC BSTE 0001238935 TWOMEY CHRISTOPHER J BIOSITE INCORPORATED 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 1 Senior Vice President Finan Senior Vice President Finan Common Stock 2007-06-29 4 U 0 210 92.5 D 0 D Incentive Stock Option (right to buy) 44.18 2007-06-29 4 D 0 2263 0 D 2014-06-18 Common Stock 2263 0 D Incentive Stock Option (right to buy) 53.38 2007-06-29 4 D 0 1873 0 D 2015-06-17 Common Stock 1873 0 D Non-Qualified Stock Option (right to buy) 44.18 2007-06-29 4 D 0 3984 0 D 2014-06-18 Common Stock 3984 0 D Non-Qualified Stock Option (right to buy) 49.15 2007-06-29 4 D 0 3750 0 D 2014-10-22 Common Stock 3750 0 D Non-Qualified Stock Option (right to buy) 53.38 2007-06-29 4 D 0 15627 0 D 2015-06-17 Common Stock 15627 0 D This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 4,054 shares of Inverness common stock for $24.66 per share. This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 3,355 shares of Inverness common stock for $29.80 per share. This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 7,137 shares of Inverness common stock for $24.66 per share. This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 6,718 shares of Inverness common stock for $27.44 per share. This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 27,997 shares of Inverness commons stock for $29.80 per share. By: Robyn Shutak For: Christopher J. Twomey 2007-06-29 -----END PRIVACY-ENHANCED MESSAGE-----